Mortality among the patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) remains high because of the very high incidence of cardiovascular disease (CVD) such as coronary artery disease, cardiac hypertrophy, and heart failure. Identifying CVD in patients with CKD/ESRD remains a significant hurdle and the early diagnosis and therapy for CVD is crucial in these patients. T...

END-STAGE RENAL DISEASE The number of patients enrolled in Medicare’s end-stage renal disease (ESRD) program has increased in near-exponential fashion over the past 30 years — from approximately 10 000 beneficiaries in 1973, to more than 86 000 in 1983, to an estimated 400 000 in 2003. As documented by data from the US Renal Data System (USRDS), about 100 000 new patients with ESRD enter the pr...

hronic kidney disease (CKD) is a significant interactive disease in patients with diabetes, hypertension, and cardiovascular disease with major morbidity and mortality consequences and high costs to the healthcare system. CKD is characterized by a gradual loss of renal function. In most parts of the world, once end-stage renal disease (ESRD) occurs, patients who do not have access to maintenanc...

There is controversy regarding whether strict blood pressure control is indicated in chronic kidney disease (CKD) since the primary results of randomized controlled trials failed to show any impact on progression of kidney disease with this strategy. However, strict blood pressure control may have other beneficial effects beyond reducing the risk of end-stage renal disease (ESRD), such as lower...

Objective: Hematological parameters including neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte (PLR), and monocyte–lymphocyte (MLR) have been demonstrated as new predictors of prognosis activity in various diseases. In this study, we aimed to investigate the associations NLR, PLR MLR with disease severity patients anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV). &#...

Sickle cell nephropathy (SCN) is a common complication of sickle cell disease (SCD). It has variable presentation, ranging from hyposthenuria to end-stage renal disease (ESRD). Management of ESRD in SCD patients is froth with multiple challenges which has potential to impact negatively the outcome of the patient. Kidney transplant is the preferred renal replacement therapy in these patients. Th...

Abstract Chronic kidney disease (CKD) affects over 10% of the global population and is more prevalent in elderly, females, patients with diabetes or hypertension, certain racial minorities. CKD a leading cause mortality, especially stage G5 End-Stage Renal Disease (ESRD). Left ventricular hypertrophy (LVH) common patients, predicting mortality even early stages. face higher risk bleeding, 3.5 t...

BACKGROUND Acute kidney injury (AKI) is a common complication after coronary artery bypass grafting (CABG) and is associated with adverse outcomes. However, the relationship between AKI after CABG and the long-term risk of end-stage renal disease (ESRD) is unknown. METHODS AND RESULTS This study included 29 330 patients who underwent primary isolated CABG in Sweden between 2000 and 2008. AKI ...

Background: End stage renal disease (ESRD) patients are vulnerable to contract corona virus disease-19 (COVID-19), and they have higher risk of deterioration mortality rate compared general population. There studies on COVID-19 in end showing the low rates deterioration, most which did not develop into severe pneumonia. Objective: Compare clinical, laboratory, radiological findings with without...